$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

$hdsn Overview Financials Valuation SEC Filings Company Website

2016 Q2 Form 10-Q Financial Statement

#000114420416116201 Filed on August 03, 2016

Income Statement

Concept	2016 Q2	2015 Q4	2015 Q2
Revenue	$34.61M	$7.300M	$28.64M
YoY Change	20.84%	-9.43%	69.7%
Cost Of Revenue	$24.11M	$5.930M	$21.43M
YoY Change	12.55%	-16.6%	46.02%
Gross Profit	$10.49M	$1.368M	$7.212M
YoY Change	45.47%	44.0%	227.52%
Gross Profit Margin	30.32%	18.74%	25.18%
Selling, General & Admin	$2.347M	$3.120M	$2.451M
YoY Change	-4.24%	6.48%	58.64%
% of Gross Profit	22.37%	228.07%	33.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$530.0K	$450.0K	$540.0K
YoY Change	-1.85%	28.57%	170.0%
% of Gross Profit	5.05%	32.89%	7.49%
Operating Expenses	$2.347M	$3.120M	$2.451M
YoY Change	-4.24%	6.48%	58.64%
Operating Profit	$8.144M	-$1.752M	$4.761M
YoY Change	71.06%	-11.52%	624.66%
Interest Expense	$352.0K	-$180.0K	$236.0K
YoY Change	49.15%	20.0%	26.88%
% of Operating Profit	4.32%		4.96%
Other Income/Expense, Net	-$352.0K	$126.0K	-$236.0K
YoY Change	49.15%		26.88%
Pretax Income	$7.792M	-$1.626M	$4.525M
YoY Change	72.2%	-23.66%	860.72%
Income Tax	$2.962M	-$603.0K	$1.714M
% Of Pretax Income	38.01%		37.88%
Net Earnings	$4.830M	-$1.023M	$2.811M
YoY Change	71.82%	-5.28%	812.66%
Net Earnings / Revenue	13.96%	-14.01%	9.82%
Basic Earnings Per Share	$0.15	-$0.03	$0.09
Diluted Earnings Per Share	$0.14	-$0.03	$0.08
COMMON SHARES
Basic Shares Outstanding	33.13M shares	32.72M shares	32.54M shares
Diluted Shares Outstanding	34.27M shares	32.72M shares	34.38M shares

Balance Sheet

Concept	2016 Q2	2015 Q4	2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.500M	$1.300M	$1.500M
YoY Change	0.0%	44.44%	-21.05%
Cash & Equivalents	$1.500M	$1.258M	$1.483M
Short-Term Investments
Other Short-Term Assets	$2.800M	$1.900M	$5.200M
YoY Change	-46.15%	35.71%	48.57%
Inventory	$57.80M	$61.90M	$44.95M
Prepaid Expenses
Receivables	$21.90M	$4.414M	$14.68M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$84.00M	$69.47M	$66.31M
YoY Change	26.68%	60.33%	58.55%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.100M	$7.536M	$7.808M
YoY Change	-9.07%	-4.45%	76.57%
Goodwill		$856.0K	$2.603M
YoY Change		223.02%
Intangibles		$3.787M	$3.522M
YoY Change		63.09%	7904.55%
Long-Term Investments
YoY Change
Other Assets	$2.000M	$76.00K	$100.0K
YoY Change	1900.0%	-25.49%	-9.91%
Total Long-Term Assets	$13.60M	$15.54M	$17.25M
YoY Change	-21.14%	-6.41%	71.75%
TOTAL ASSETS
Total Short-Term Assets	$84.00M	$69.47M	$66.31M
Total Long-Term Assets	$13.60M	$15.54M	$17.25M
Total Assets	$97.60M	$85.01M	$83.55M
YoY Change	16.81%	41.84%	61.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.900M	$5.800M	$17.80M
YoY Change	-72.47%	28.89%	169.7%
Accrued Expenses	$3.100M	$4.600M	$400.0K
YoY Change	675.0%	1050.0%	33.33%
Deferred Revenue
YoY Change
Short-Term Debt	$25.60M	$0.00	$0.00
YoY Change
Long-Term Debt Due	$300.0K	$346.0K	$10.30M
YoY Change	-97.09%	31.06%	3333.33%
Total Short-Term Liabilities	$35.60M	$30.96M	$28.48M
YoY Change	24.99%	176.08%	299.87%
LONG-TERM LIABILITIES
Long-Term Debt	$4.100M	$4.293M	$4.441M
YoY Change	-7.68%	-2.19%	741.1%
Other Long-Term Liabilities	$0.00	$333.0K	$1.533M
YoY Change	-100.0%	0.0%
Total Long-Term Liabilities	$4.100M	$4.626M	$5.974M
YoY Change	-31.37%	-2.03%	1031.44%
TOTAL LIABILITIES
Total Short-Term Liabilities	$35.60M	$30.96M	$28.48M
Total Long-Term Liabilities	$4.100M	$4.626M	$5.974M
Total Liabilities	$39.70M	$35.59M	$34.46M
YoY Change	15.22%	123.31%	350.36%
SHAREHOLDERS EQUITY
Retained Earnings		-$13.07M	-$13.13M
YoY Change		-26.71%	-21.13%
Common Stock	$332.0K	$328.0K	$326.0K
YoY Change	1.84%	1.55%	1.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$57.80M	$49.43M	$49.10M
YoY Change
Total Liabilities & Shareholders Equity	$97.60M	$85.01M	$83.55M
YoY Change	16.81%	41.84%	61.11%

Cashflow Statement

Concept	2016 Q2	2015 Q4	2015 Q2
OPERATING ACTIVITIES
Net Income	$4.830M	-$1.023M	$2.811M
YoY Change	71.82%	-5.28%	812.66%
Depreciation, Depletion And Amortization	$530.0K	$450.0K	$540.0K
YoY Change	-1.85%	28.57%	170.0%
Cash From Operating Activities	$1.570M	-$5.000M	$310.0K
YoY Change	406.45%	69.49%	-84.34%
INVESTING ACTIVITIES
Capital Expenditures	-$390.0K	-$250.0K	-$490.0K
YoY Change	-20.41%	31.58%	145.0%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$390.0K	-$250.0K	-$490.0K
YoY Change	-20.41%	-96.69%	206.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-820.0K	5.470M	1.200M
YoY Change	-168.33%	-46.74%	-149.79%
NET CHANGE
Cash From Operating Activities	1.570M	-5.000M	310.0K
Cash From Investing Activities	-390.0K	-250.0K	-490.0K
Cash From Financing Activities	-820.0K	5.470M	1.200M
Net Change In Cash	360.0K	220.0K	1.020M
YoY Change	-64.71%	-195.65%	-272.88%
FREE CASH FLOW
Cash From Operating Activities	$1.570M	-$5.000M	$310.0K
Capital Expenditures	-$390.0K	-$250.0K	-$490.0K
Free Cash Flow	$1.960M	-$4.750M	$800.0K
YoY Change	145.0%	72.1%	-63.3%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	2590000	USD
CY2015Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	3018000	USD
CY2016Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	24114000	USD
CY2015Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	21425000	USD
CY2016Q2	us-gaap	Gross Profit GrossProfit	10491000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7792000	USD
CY2015Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	4525000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2962000	USD
CY2015Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1714000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	4830000	USD
CY2015Q2	us-gaap	Net Income Loss NetIncomeLoss	2811000	USD
CY2015Q2	us-gaap	Gross Profit GrossProfit	7212000	USD
CY2016Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1019000	USD
CY2015Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1397000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	2347000	USD
CY2015Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	4761000	USD
CY2016Q2	us-gaap	Interest Expense InterestExpense	352000	USD
CY2015Q2	us-gaap	Interest Expense InterestExpense	236000	USD
CY2016Q2	us-gaap	Revenues Revenues	34605000	USD
CY2015Q2	us-gaap	Revenues Revenues	28637000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32542672	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1143000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	48000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	34000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	77000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	72000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	62000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	1344000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2819000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17593000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10755000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4123000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	2451000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	8144000	USD
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33128518	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34270337	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34383092	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1083000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	76000	USD
CY2015Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	5792000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4766000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	7588000	USD
CY2016Q2	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	4906000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2884000	USD
	us-gaap	Operating Expenses OperatingExpenses	4850000	USD
	us-gaap	Operating Expenses OperatingExpenses	4706000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	13163000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	8031000	USD
CY2016Q2	us-gaap	Common Stock Value CommonStockValue	332000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	12540000	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	328000	USD
	us-gaap	Revenues Revenues	62772000	USD
	us-gaap	Revenues Revenues	50740000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2136000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2014000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2714000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2692000	USD
	us-gaap	Interest Expense InterestExpense	623000	USD
	us-gaap	Interest Expense InterestExpense	443000	USD
	us-gaap	Net Income Loss NetIncomeLoss	7774000	USD
	us-gaap	Net Income Loss NetIncomeLoss	4704000	USD
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.24
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	33008588	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32454175	shares
CY2016Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	2319000	USD
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34045125	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	34254901	shares
CY2015Q2	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1054000	USD
CY2016Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1328000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	548000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6486000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	907000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3849000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-1879000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	11799000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-4148000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-498000	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	0	USD
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	2424000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	517000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	549000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-517000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2973000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	593000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	317000	USD
CY2015Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1483000	USD
	us-gaap	Interest Paid InterestPaid	551000	USD
	us-gaap	Interest Paid InterestPaid	381000	USD
	hdsn	Noncash Or Par Tnoncash Deferred Acquisition Consideration NoncashOrParTnoncashDeferredAcquisitionConsideration	1069000	USD
	hdsn	Noncash Or Par Tnoncash Deferred Acquisition Consideration NoncashOrParTnoncashDeferredAcquisitionConsideration	2700000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	5369000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt ProceedsFromRepaymentsOfShortTermDebt	3887000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	286000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	935000	USD
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	1991-01-11
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	60276000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	48172000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2496000	USD
	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	2568000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	187000	shares
CY2013	hdsn	Production Or Importation Of Hcfc ProductionOrImportationOfHcfc	63000000	lb
CY2014	hdsn	Production Or Importation Of Hcfc ProductionOrImportationOfHcfc	51000000	lb
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	77000	USD
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6000000	shares
CY2016Q2	us-gaap	Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance	4389023	shares
CY2016Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	2000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0101	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.47	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	306000	USD
CY2015Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1309000	USD
CY2013Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	5435000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	2335000	USD
CY2014Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	265000	USD
CY2014Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	8035000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	165000	USD
CY2015Q4	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	170000	USD
CY2015Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	335000	USD
CY2015Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment	1606000	USD
CY2015Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles	1500000	USD
CY2015Q1	us-gaap	Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount	2338000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	3000000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1000000	USD
CY2015	hdsn	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill	1900000	USD
CY2015	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles	800000	USD
CY2015	us-gaap	Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory	100000	USD
CY2015	us-gaap	Business Combination Contingent Consideration Arrangements Change In The Range Of Outcomes Contingent Consideration Liability Value High BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh	1100000	USD
CY2015Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	900000	USD
CY2015	hdsn	Business Combination Earnout Liabilitycash Paid BusinessCombinationEarnoutLiabilitycashPaid	445000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2016-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	HUDSON TECHNOLOGIES INC /NY
	dei	Entity Central Index Key EntityCentralIndexKey	0000925528
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	HDSN
CY2016Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33612109	shares
CY2016Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	33199249	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32804617	shares
CY2016Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	33199249	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32804617	shares
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	267000	USD
	hdsn	Payment Of Deferred Acquisition Cost PaymentOfDeferredAcquisitionCost	833000	USD
	hdsn	Payment Of Deferred Acquisition Cost PaymentOfDeferredAcquisitionCost	300000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1757000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	179000	USD
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Credit Risk</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the six month period ended June 30, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>one customer accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 25</font>% of the Company’s revenues<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>. At June 30, 2016, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,100,000</font> in outstanding receivables from this customer.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">For the six month period ended June 30, 2015, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>two customers each accounted for 10% or more of the Company’s revenues<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 35</font>% of the Company’s revenues. At June 30, 2015, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,309,000</font> in outstanding receivables from these customers.</div>  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have a material adverse effect on the Company's operating results and financial position.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><strong>Estimates and Risks</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Several of the Company's accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company participates in an industry that is highly regulated, and changes in the regulations affecting our business could affect our operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In April 2013, the Environmental Protection Agency (“EPA”) published a final rule providing for the production or importation of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">63</font> million and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">51</font> million pounds of HCFC-22 in 2013 and 2014, respectively. In October 2014, the EPA published a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the “Final Rule”). In the Final Rule, the EPA has established a linear draw down for the production or importation of virgin HCFC-22 that started at approximately<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020.</div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
	us-gaap	Concentration Risk Customer ConcentrationRiskCustomer	two customers each accounted for 10% or more of the Companys revenues
	hdsn	Production And Importation Permission Description ProductionAndImportationPermissionDescription	22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020.
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2016Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3776000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P2Y
	us-gaap	Line Of Credit Facility Interest Rate Description LineOfCreditFacilityInterestRateDescription	Interest charges with respect to loans are computed on the actual principal amount of loans outstanding during the month at a rate per annum equal to (A) with respect to Domestic Rate Loans (as defined in the PNC Facility), the sum of the Alternate Base Rate (as defined in the PNC Facility) plus one half of one percent (.50%) and (B) with respect to Eurodollar Rate Loans, the sum of the Eurodollar Rate plus two and one quarter of one percent (2.25%).
CY2016Q2	us-gaap	Line Of Credit LineOfCredit	29596000	USD
CY2016Q2	us-gaap	Line Of Credit Facility Current Borrowing Capacity LineOfCreditFacilityCurrentBorrowingCapacity	20404000	USD
CY2016Q2	us-gaap	Line Of Credit Facility Interest Rate At Period End LineOfCreditFacilityInterestRateAtPeriodEnd	0.0300	pure
CY2015Q1	hdsn	Business Acquisition Purchase Price Allocation Description BusinessAcquisitionPurchasePriceAllocationDescription	The purchase price for this acquisition was $2,424,000 cash paid at closing and the assumption of a liability of $20,000, and a maximum of an additional $3,000,000 earn-out.
	hdsn	Business Combination Earnout Liabilitycash Paid BusinessCombinationEarnoutLiabilitycashPaid	129000	USD
CY2016Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	771000	USD
CY2016Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1665000	USD
CY2015Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2016Q2	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	25596000	USD
CY2015Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	20227000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	1665000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	0	USD
	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	All of the Company’s remaining NOLs of approximately $5,000,000 are subject to annual limitations of $1,300,000.

Files In Submission

Name	View Source	Status
0001144204-16-116201-index-headers.html	Edgar Link	pending
0001144204-16-116201-index.html	Edgar Link	pending
0001144204-16-116201.txt	Edgar Link	pending
0001144204-16-116201-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hdsn-20160630.xml	Edgar Link	completed
hdsn-20160630.xsd	Edgar Link	pending
hdsn-20160630_cal.xml	Edgar Link	unprocessable
hdsn-20160630_def.xml	Edgar Link	unprocessable
hdsn-20160630_lab.xml	Edgar Link	unprocessable
hdsn-20160630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v445329_10q.htm	Edgar Link	pending
v445329_ex31-1.htm	Edgar Link	pending
v445329_ex31-2.htm	Edgar Link	pending
v445329_ex32-1.htm	Edgar Link	pending
v445329_ex32-2.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2016 Q2 Form 10-Q Financial Statement

#000114420416116201 Filed on August 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN HUDSON TECHNOLOGIES INC /NY Stock $hdsn

2016 Q2 Form 10-Q Financial Statement

#000114420416116201 Filed on August 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HDSN
HUDSON TECHNOLOGIES INC /NY Stock $hdsn